Found: 57
Select item for more details and to access through your institution.
Brentuximab Vedotin for Relapsed or Refractory Sézary Syndrome.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Infection dynamics of COVID-19 virus under lockdown and reopening.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-05333-5
- By:
- Publication type:
- Article
CAR‐T TREK through the lymphoma universe, to boldly go where no other therapy has gone before.
- Published in:
- British Journal of Haematology, 2021, v. 193, n. 3, p. 449, doi. 10.1111/bjh.17191
- By:
- Publication type:
- Article
Checkpoint blockade treatment sensitises relapsed/refractory non‐Hodgkin lymphoma to subsequent therapy.
- Published in:
- British Journal of Haematology, 2020, v. 191, n. 1, p. 44, doi. 10.1111/bjh.16756
- By:
- Publication type:
- Article
Pembrolizumab in relapsed or refractory Richter syndrome.
- Published in:
- British Journal of Haematology, 2020, v. 190, n. 2, p. e117, doi. 10.1111/bjh.16762
- By:
- Publication type:
- Article
What is the standard of care for primary mediastinal B cell lymphoma; R‐CHOP or DA‐EPOCH‐R? – Response to Melani et al.
- Published in:
- British Journal of Haematology, 2019, v. 184, n. 5, p. 838, doi. 10.1111/bjh.15183
- By:
- Publication type:
- Article
Outcomes of adults and children with primary mediastinal B-cell lymphoma treated with dose-adjusted EPOCH-R.
- Published in:
- British Journal of Haematology, 2017, v. 179, n. 5, p. 739, doi. 10.1111/bjh.14951
- By:
- Publication type:
- Article
Nelarabine, cyclosphosphamide and etoposide for adults with relapsed T-cell acute lymphoblastic leukaemia and lymphoma.
- Published in:
- British Journal of Haematology, 2016, v. 174, n. 2, p. 332, doi. 10.1111/bjh.13771
- By:
- Publication type:
- Article
Front-line, dose-escalated immunochemotherapy is associated with a significant progression-free survival advantage in patients with double-hit lymphomas: a systematic review and meta-analysis.
- Published in:
- British Journal of Haematology, 2015, v. 170, n. 4, p. 504, doi. 10.1111/bjh.13463
- By:
- Publication type:
- Article
'Double-Hit' cytogenetic status may not be predicted by baseline clinicopathological characteristics and is highly associated with overall survival in B cell lymphoma patients.
- Published in:
- British Journal of Haematology, 2014, v. 166, n. 3, p. 369, doi. 10.1111/bjh.12901
- By:
- Publication type:
- Article
Could treatment with R- HCVAD/ R- MA as compared to R- CHOP truly result in improved outcomes for patients with high-risk diffuse large B cell lymphoma?
- Published in:
- British Journal of Haematology, 2014, v. 165, n. 1, p. 145, doi. 10.1111/bjh.12702
- By:
- Publication type:
- Article
PRVNÍ VÝSLEDKY TESTOVÁNÍ VLIVU INSEKTICIDŮ NA MRAVENCE.
- Published in:
- Vedecke Prace Ovocnarske, 2023, v. 29, n. 1, p. 35
- By:
- Publication type:
- Article
Analysis of Behavioural Factors Influencing Investment Decisions: A Literature Review.
- Published in:
- Trends: Economics & Management / Trendy: Ekonomiky a Managementu, 2022, v. 16, n. 39, p. 47, doi. 10.13164/trends.2022.39.47
- By:
- Publication type:
- Article
Patterns of immune checkpoint protein expression in MYC-overexpressing aggressive B-cell non-Hodgkin lymphomas.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 3, p. 869, doi. 10.1007/s00262-020-02708-3
- By:
- Publication type:
- Article
<sup>18</sup>F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Following Chimeric Antigen Receptor T-cell Therapy in Large B-cell Lymphoma.
- Published in:
- Molecular Imaging & Biology, 2021, v. 23, n. 6, p. 818, doi. 10.1007/s11307-021-01627-8
- By:
- Publication type:
- Article
Microstructure Characterization and Corrosion Resistance of Zinc Coating Obtained in a Zn-AlNiBi Galvanizing Bath.
- Published in:
- Coatings (2079-6412), 2020, v. 10, n. 8, p. 758, doi. 10.3390/coatings10080758
- By:
- Publication type:
- Article
Prevalence and Prognostication of CD5+ Mature T-Cell Lymphomas.
- Published in:
- Cancers, 2024, v. 16, n. 19, p. 3430, doi. 10.3390/cancers16193430
- By:
- Publication type:
- Article
Atorvastatin for Anthracycline-Associated Cardiac Dysfunction: The STOP-CA Randomized Clinical Trial.
- Published in:
- JAMA: Journal of the American Medical Association, 2023, v. 330, n. 6, p. 528, doi. 10.1001/jama.2023.11887
- By:
- Publication type:
- Article
Structure and plastic deformation of metastable Ag–Cu metal-matrix composites produced by a bottom-up way from Cu@Ag core–shell powders.
- Published in:
- Journal of Materials Science, 2024, v. 59, n. 31, p. 14728, doi. 10.1007/s10853-024-10053-4
- By:
- Publication type:
- Article
The role of FDG- PET imaging as a prognostic marker of outcome in primary mediastinal B-cell lymphoma.
- Published in:
- Cancer Medicine, 2015, v. 4, n. 1, p. 7, doi. 10.1002/cam4.322
- By:
- Publication type:
- Article
Extracavitary primary effusion lymphoma initially presenting with hemophagocytic lymphohistocytosis.
- Published in:
- 2014
- By:
- Publication type:
- journal article
The Utilization of WasteWater from a Concrete Plant in the Production of Cement Composites.
- Published in:
- Buildings (2075-5309), 2017, v. 7, n. 4, p. 120, doi. 10.3390/buildings7040120
- By:
- Publication type:
- Article
Sound-Absorbing and Thermal-Insulating Properties of Cement Composite Based on Recycled Rubber from Waste Tires.
- Published in:
- Applied Sciences (2076-3417), 2021, v. 11, n. 6, p. 2725, doi. 10.3390/app11062725
- By:
- Publication type:
- Article
Reuse of Waste Material "Waste Sludge Water" from a Concrete Plant in Cement Composites: A Case Study.
- Published in:
- Applied Sciences (2076-3417), 2019, v. 9, n. 21, p. 4519, doi. 10.3390/app9214519
- By:
- Publication type:
- Article
Outcomes of Tisagenlecleucel in Lymphoma Patients With Predominant Management in an Ambulatory Setting.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 8, p. e730, doi. 10.1016/j.clml.2022.04.012
- By:
- Publication type:
- Article
Ibrutinib-associated Arthralgias/Myalgias in Patients With Chronic Lymphocytic Leukemia: Incidence and Impact on Clinical Outcomes.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Treatment of Patients With Relapsed/Refractory Non-Hodgkin Lymphoma With Venetoclax: A Single-Center Evaluation of Off-Label Use.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Multicenter Analysis of Advanced Stage Grade 3A Follicular Lymphoma Outcomes by Frontline Treatment Regimen.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Bexarotene in Patients With Peripheral T-cell Lymphomas: Results of a Retrospective Study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Evidence for and Against Green Tea and Turmeric in the Management of Chronic Lymphocytic Leukemia.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Interim PET/CT Result Is Not Predictive of Survival in Patients With MYC-rearranged Non-Burkitt Aggressive B-cell Lymphoma.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Classical Hodgkin Lymphoma Treatment Patterns, Molecular Profiling, and Clinical Outcomes in US Oncology Practices: A Prospective Observational Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2018, v. 18, p. S234, doi. 10.1016/j.clml.2018.07.117
- By:
- Publication type:
- Article
Immunotherapy for the Treatment of Hodgkin Lymphoma: An Evolving Paradigm.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Chimeric Antigen Receptor T-Cell Therapy for Chronic Lymphocytic Leukemia: A Narrative Review.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Conformation‐based refinement of 18‐mer DNA structures.
- Published in:
- Acta Crystallographica: Section D, Structural Biology, 2023, v. 79, n. 7, p. 655, doi. 10.1107/S2059798323004679
- By:
- Publication type:
- Article
Structural variability of CG‐rich DNA 18‐mers accommodating double T–T mismatches.
- Published in:
- Acta Crystallographica: Section D, Structural Biology, 2020, v. 76, n. 12, p. 1233, doi. 10.1107/S2059798320014151
- By:
- Publication type:
- Article
Mogamulizumab Multimodality Therapy with Systemic Retinoids, Interferon, or Extracorporeal Photopheresis for Advanced Cutaneous T-Cell Lymphoma.
- Published in:
- Dermatologic Therapy, 2023, p. 1, doi. 10.1155/2023/7625926
- By:
- Publication type:
- Article
Efficacy and safety of bendamustine for lymphodepletion before lisocabtagene maraleucel.
- Published in:
- Journal of Hematology & Oncology, 2024, v. 17, n. 1, p. 1, doi. 10.1186/s13045-024-01542-9
- By:
- Publication type:
- Article
Amplifiers of selection for the Moran process with both Birth-death and death-Birth updating.
- Published in:
- PLoS Computational Biology, 2024, v. 20, n. 3, p. 1, doi. 10.1371/journal.pcbi.1012008
- By:
- Publication type:
- Article
Safety and activity of ibrutinib in combination with durvalumab in patients with relapsed or refractory follicular lymphoma or diffuse large B‐cell lymphoma.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 1, p. 18, doi. 10.1002/ajh.25659
- By:
- Publication type:
- Article
Outcomes of front‐line ibrutinib treated CLL patients excluded from landmark clinical trial.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 11, p. 1394, doi. 10.1002/ajh.25261
- By:
- Publication type:
- Article
Outcomes of patients with relapsed/refractory Hodgkin lymphoma progressing after autologous stem cell transplant in the current era of novel therapeutics: A retrospective analysis.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 9, p. 879, doi. 10.1002/ajh.24792
- By:
- Publication type:
- Article
Autologous stem cell transplantation in first complete remission may not extend progression-free survival in patients with peripheral T cell lymphomas.
- Published in:
- American Journal of Hematology, 2016, v. 91, n. 7, p. 672, doi. 10.1002/ajh.24372
- By:
- Publication type:
- Article
Reduced-dose fludarabine, cyclophosphamide, and rituximab (FCR-Lite) plus lenalidomide, followed by lenalidomide consolidation/maintenance, in previously untreated chronic lymphocytic leukemia.
- Published in:
- American Journal of Hematology, 2015, v. 90, n. 6, p. 487, doi. 10.1002/ajh.23983
- By:
- Publication type:
- Article
Outcomes of patients with relapsed/refractory diffuse large B-cell lymphoma with progression of lymphoma after autologous stem cell transplantation in the rituximab era.
- Published in:
- American Journal of Hematology, 2013, v. 88, n. 10, p. 890, doi. 10.1002/ajh.23524
- By:
- Publication type:
- Article
Winter course experience: Towards a wider understanding of a dramaturgy approach.
- Published in:
- Acta Gymnica, 2015, v. 45, n. 4, p. 167, doi. 10.5507/ag.2015.020
- By:
- Publication type:
- Article
A unified dinucleotide alphabet describing both RNA and DNA structures.
- Published in:
- Nucleic Acids Research, 2020, v. 48, n. 11, p. 6367, doi. 10.1093/nar/gkaa383
- By:
- Publication type:
- Article
Combined lenalidomide, low-dose dexamethasone, and rituximab achieves durable responses in rituximab-resistant indolent and mantle cell lymphomas.
- Published in:
- Cancer (0008543X), 2014, v. 120, n. 2, p. 222, doi. 10.1002/cncr.28405
- By:
- Publication type:
- Article
Post-treatment (not interim) positron emission tomography-computed tomography scan status is highly predictive of outcome in mantle cell lymphoma patients treated with R-HyperCVAD.
- Published in:
- Cancer (0008543X), 2012, v. 118, n. 14, p. 3565, doi. 10.1002/cncr.26731
- By:
- Publication type:
- Article
Management of patients with post-transplant lymphoproliferative disorder: the role of rituximab.
- Published in:
- Transplant International, 2006, v. 19, n. 4, p. 259, doi. 10.1111/j.1432-2277.2006.00284.x
- By:
- Publication type:
- Article